VAERS Explorer
Back to explore

Report #2879561

Received Dec 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
18 yrs
State
MS
Recovered
Unknown
Vaccinated
Dec 10, 2025
Onset
Dec 10, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALS1DD7F7—

Symptoms (1)

Expired product administered

Symptom narrative

expired dose of Boostrix administered to patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 18-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number DD7F7, expiry date 06-DEC-2025) for prophylaxis. On 10-DEC-2025, the patient received the 1st dose of Boostrix. On 10-DEC-2025, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: expired dose of Boostrix administered to patient). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.